• 1
    Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Dwarki VJ, Gromkowski SH, Deck RR, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 17451749.
  • 2
    Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson LA. DNA vaccines: Protective immunizations by parenteral, niucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A 1993; 90: 1147811482.
  • 3
    Cox GJ, Zamb TJ, Babiuk LA. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol 1993; 67: 56645667.
  • 4
    Wang B, Ugen KE, Srikantan V, Agadjanian MG, Dang K, Refaeli Y, Sato AI, et al. Gene inoculation generates immune responses against immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1993; 90: 41564160.
  • 5
    Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 1994; 199: 132140.
  • 6
    Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miya-mura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362364.
  • 7
    Weiner AJ, Geysen HM, Christopher son C, Hall JE, Mason TJ, Saracco G, Bonino F, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 1992; 89: 34683472.
  • 8
    Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, Shimotohno K Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 1994; 68: 47764784.
  • 9
    Kojima M, Osuga T, Tanaka T, Okamoto H. Influence of antibodies to the hypervariable region E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees. Virology 1994; 204: 665672.
  • 10
    Kumar U, Monjardino J, Thomas HC. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 1994; 106: 10721075.
  • 11
    Prince AM, Brotman B, Huima T, Pascual D, Jaffery M, Inchauspe G. Immunity in hepatitis C infection. J Infect Dis 1992; 165: 438443.
  • 12
    Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135140.
  • 13
    Choo Q-L, Kuo G, Ralston R, Weiner A, Chien D, Han G, Van Nest J, et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A 1994; 91: 12941298.
  • 14
    Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992; 149: 33393344.
  • 15
    Koziel MJ, Dudley D, Afdahl N, Choo Q-L, Houghton M, Ralston R, Walker BD. Hepatitis C virus-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope regions of HCV. J Virol 1993; 67: 75227528.
  • 16
    Choo Q-L, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991; 88: 24512455.
  • 17
    Hsu H, Donets M, Greenberg HB, Feinstone SM. Characterization of hepatitis C virus structural proteins with a recombinant baculovirus expression system. Hepatology 1993; 17: 763771.
  • 18
    Kozak M. The scanning model for translation: an update. J Cell Biol 1989; 108: 229241.
  • 19
    Akatsuka T, Donets M, Scaglione L, Ching W-M, Shih J W-K, Di Bisceglie AM, Feinstone SM. B-cell epitopes to the hepatitis C virus nucleocapsid protein determined by human monospecific antibodies. Hepatology 1993; 18: 503510.
  • 20
    Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992; 6: 363369.
  • 21
    Davis HL, Michel ML, Whalen R. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet 1993; 2: 18471851.
  • 22
    Ching W-M, Wychovski C, Beach MJ, Wang H, Davies CL, Carl M, Bradley DW, et al. Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus. Proc Natl Acad Sci U S A 1992; 89: 31903194.
  • 23
    Weiner A, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180: 842848.
  • 24
    Mink MA, Benichou S, Madaule P, Tiollais P, Prince AM, Inchauspe G. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. Virology 1994; 200: 246255.
  • 25
    Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Feigner PL. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 14651468.
  • 26
    Swirski RA, Van Den Berg D, Murphy AJM, Lambert CM, Friedberg EC, Schimke RT. Improvements on the Epstein-Barr-based shuttle vector system for direct cloning in human tissue culture cells. Comparative Methods in Enzymology 1992; 4: 133142.
  • 27
    Lupton S, Levine AJ. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol Cell Biol 1985; 5: 25332542.
  • 28
    Thomason DB, Booth FW. Stable incorporation of a bacterial gene into adult rat skeletal muscle. Am J Physiol 1985; 258: C578C581.
  • 29
    Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A 1996; 93: 17591763.